"Designing Growth Strategies is in our DNA"

U.S. Antipsychotic Drugs Market Size, Share & COVID-19 Impact Analysis, By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, and Others), By Drug (Risperidone, Quetiapine, Olanzapine, Aripiprazole, Brexpiprazole, Paliperidone Palmitate, and Others), By Therapeutic Class (First Generation, Second Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI109192

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Psychiatric Disorders, 2023
    2. Analysis of the Cost and Burden of Mental Health Disorders
    3. Overview of Current Advances in R&D for Antipsychotic Drugs
    4. Pipeline Analysis
    5. Analysis of Antipsychotics in Treatment of Dementia
    6. Analysis: First Generation Antipsychotics vs. Third Generation Antipsychotics
    7. Key Industry Developments
    8. New Product Launches
    9. Impact of COVID-19 on Antipsychotic Drugs Market
  5. U.S. Antipsychotic Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast– By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    2. Market Analysis, Insights and Forecast– By Drug
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    3. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Otsuka Pharmaceutical Co., Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Dr. Reddy’s Laboratories Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. H. Lundbeck A/S
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. ALLERGAN (AbbVie, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Eli Lilly and Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Alkermes plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Bristol-Myers Squibb Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. Sumitomo Dainippon Pharma Co., Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Psychiatric Disorders, 2023
    2. Analysis of the Cost and Burden of Mental Health Disorders
    3. Overview of Current Advances in R&D for Antipsychotic Drugs
    4. Pipeline Analysis
    5. Analysis of Antipsychotics in Treatment of Dementia
    6. Analysis: First Generation Antipsychotics vs. Third Generation Antipsychotics
    7. Key Industry Developments
    8. New Product Launches
    9. Impact of COVID-19 on Antipsychotic Drugs Market
  5. U.S. Antipsychotic Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast– By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    2. Market Analysis, Insights and Forecast– By Drug
      1. Risperidone
      2. Quetiapine
      3. Olanzapine
      4. Aripiprazole
      5. Brexpiprazole
      6. Paliperidone Palmitate
      7. Others
    3. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Otsuka Pharmaceutical Co., Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Dr. Reddy’s Laboratories Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. H. Lundbeck A/S
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. ALLERGAN (AbbVie, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Eli Lilly and Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Alkermes plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Bristol-Myers Squibb Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. Sumitomo Dainippon Pharma Co., Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Table 01: U.S. Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 02: U.S. Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Drug, 2019–2030

Table 03: U.S. Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Therapeutic Class, 2019–2030

Table 04: U.S. Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Figure 01: U.S. Antipsychotic Drugs Market Revenue Breakdown (USD billion, %), By Disease, 2022 & 2030

Figure 02: U.S. Antipsychotic Drugs Market Value Share (%), By Disease, 2022 & 2030

Figure 03: U.S. Antipsychotic Drugs Market Value Share (%), By Drug, 2022 & 2030

Figure 04: U.S. Antipsychotic Drugs Market Value Share (%), By Therapeutic Class, 2022 & 2030

Figure 05: U.S. Antipsychotic Drugs Market Value Share (%), By Distribution Channel, 2022 & 2030

Figure 06: U.S. Antipsychotic Drugs Market Share Analysis (%), By Company, 2022

U.S. Antipsychotic Drugs Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports